Correlation Between Takeda Pharmaceutical and Teva Pharma

Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Teva Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Teva Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Takeda Pharmaceutical Co and Teva Pharma Industries, you can compare the effects of market volatilities on Takeda Pharmaceutical and Teva Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Teva Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Teva Pharma.

Diversification Opportunities for Takeda Pharmaceutical and Teva Pharma

-0.56

Correlation Coefficient

Takeda Pharmaceutical  Teva Pharma

Excellent diversification

The 3 months correlation between Takeda and Teva is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Teva Pharma Industries in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Teva Pharma Industries and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Teva Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Teva Pharma Industries has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Teva Pharma go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and Teva Pharma

Assuming the 90 days horizon Takeda Pharmaceutical Co is expected to under-perform the Teva Pharma. But the pink sheet apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 1.04 times less risky than Teva Pharma. The pink sheet trades about -0.18 of its potential returns per unit of risk. The Teva Pharma Industries is currently generating about -0.14 of returns per unit of risk over similar time horizon. If you would invest  1,348  in Teva Pharma Industries on January 20, 2024 and sell it today you would lose (70.00) from holding Teva Pharma Industries or give up 5.19% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.45%
Values	Daily Returns

Takeda Pharmaceutical Co  vs.  Teva Pharma Industries

Takeda Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's technical indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Teva Pharma Industries

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Teva Pharma Industries are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Teva Pharma may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pair Trading with Takeda Pharmaceutical and Teva Pharma

The main advantage of trading using opposite Takeda Pharmaceutical and Teva Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Teva Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Teva Pharma will offset losses from the drop in Teva Pharma's long position.

The idea behind Takeda Pharmaceutical Co and Teva Pharma Industries pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.